A mechanistic biopsy study of the effect of iptacopan on immunopathology in patients with IgA nephropathy (IgAN)
用户qp_rRVG66gHo
1个月前
83
10
已完结
1. 系统已在2026-03-18 10:30:26对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
D Rizk, B Maes, H Zhang…
Nephrology …, 2025
medcommshydhosting.com
• Overactivation of the alternative pathway is one of the key drivers of IgAN. Targeting the alternative pathway may address an unmet need for targeted immunomodulation and result in the improvement of kidney function and prevention of disease progression1, 2• Iptacopan is a proximal complement inhibitor that targets factor B to specifically inhibit the alternative complement pathway while leaving signaling from the lectin and classical pathways intact1, 3, 4
